ArticleAsian Pacific journal of cancer prevention : APJCP2025
The DNA Methylation is Involved in Liver Cancer Metastasis via Regulation of E- cadherin Gene.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over 90% of primary liver tumors are hepatocellular carcinomas (HCCs). In mammalian cells, chromatin remodeling and transcription regulation are significantly influenced by DNA methylation. Many cancers demonstrate both generalized DNA hypomethylation and localized DNA hypermethylation. Epithelial Cadherin (E-cadherin), a critical molecule in cell adhesion and cancer progression, is involved in these processes. This study aimed to investigate the biological role of DNA methyltransferase 1 (DNMT1) in HCC and its association with E-cadherin gene expression in HCC development. The study included 120 HCC patients from Egypt and 25 healthy individuals. Peripheral blood samples were collected from both groups, and quantitative real-time PCR was utilized to measure the expression levels of the E-cadherin and DNMT1 genes. All participants underwent a comprehensive medical history review and clinical examination. Additionally, the patients had laboratory tests, including serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST), α-fetoprotein (AFP), albumin, serum creatinine, total leukocyte count (TLC), and platelet count. The results revealed significantly higher levels of these biochemical markers in the HCC group compared to the control group (P values < 0.005). Notably, DNMT1 expression was significantly higher in HCC samples compared to those from healthy controls. In contrast, the expression of E-cadherin was significantly reduced in the HCC group. Furthermore, our findings revealed that the relative gene expression of DNMT1 was negatively correlated with the relative gene expression of E-cadherin, AFP, and tumor size, while E-cadherin expression was negatively correlated with AFP and tumor size. These results suggest that DNMT1 may play a vital role in regulating E-cadherin expression, which could influence the migratory behavior of HCC cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.